Clinical Trial

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Name: A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors — clinical trial record (NCT07092748)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase Ia/Ib, dose escalation and dose expansion study to evaluate the safety, tolerability, PK, and preliminary efficacy of HS387 in subjects with advanced solid tumors. It includes two parts: the dose escalation study (Phase Ia) and the dose expansion study (Phase Ib)

Trial Details

NCT Number	NCT07092748
Lead Sponsor	Zhejiang Hisun Pharmaceutical Co. Ltd.
Conditions	Advanced Solid Cancers
Enrollment	110 participants
Start Date	2025-07-15
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-30